Serious adverse event caused by combined target therapy (CROSBI ID 68001)
Prilog u knjizi | stručni rad
Podaci o odgovornosti
Poduje, Sanja ; Marić Brozić, Jasmina ; Prkačin, Ivana ; Delaš Aždajić, Marija ; Goren, Andy
engleski
Serious adverse event caused by combined target therapy
Combined target therapy commonly causes mild to moderate adverse events on the skin (such as rash, hyperkeratosis and photosensitivity reaction). Serious adverse events such as Stevens-Johnson syndrome and toxic epidermal necrolysis induced by combined therapy are rare, but life-threating conditions and should be recognized and treated on time.
combined target therapy ; toxic epidermal necrolysis ; metastatic melanoma
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
5-8.
objavljeno
10.1007/978-3-030-50820-3
Podaci o knjizi
Clinical cases in melanoma
Lotti, Torello ; Tirant, Michael ; Wollina, Uwe
Cham: Springer
2020.
978-3-030-50819-7
2730-6178